Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy

[1]  A. Kazemian,et al.  Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial. , 2009, European journal of cancer care.

[2]  T. Sendo,et al.  Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia. , 2008, International journal of clinical pharmacology and therapeutics.

[3]  D. Thompson,et al.  Risk factors for oral mucositis in children undergoing chemotherapy: a matched case-control study. , 2008, Oral oncology.

[4]  J. P. Lauris,et al.  Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. , 2008, Oral diseases.

[5]  A. Rosas-López,et al.  [Acute lymphoblastic leukemia: experience in adult patients treated with hyperCVAD and 0195 Protocol, at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Cohort 2003-2007]. , 2008, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[6]  H. Einsele,et al.  Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Sonis.  Pathobiology of oral mucositis: novel insights and opportunities. , 2007, The journal of supportive oncology.

[8]  Mark L. Greenberg,et al.  Validation of the oral mucositis assessment scale in pediatric cancer , 2007, Pediatric blood & cancer.

[9]  G. Oster,et al.  Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. , 2007, The journal of supportive oncology.

[10]  S. Sonis,et al.  Nuclear factor-κB (NF-κB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy , 2007 .

[11]  J. Raber-Durlacher,et al.  Updated clinical practice guidelines for the prevention and treatment of mucositis , 2007, Cancer.

[12]  S. Elad,et al.  A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation , 2006, Bone Marrow Transplantation.

[13]  P. López‐Jornet,et al.  A simple test for salivary gland hypofunction using Oral Schirmer's test. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[14]  S. Vokurka,et al.  Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study , 2006, Supportive Care in Cancer.

[15]  Howard C. Tenenbaum,et al.  The relationship between mouthrinse matrix metalloproteinases (MMP-1, 8, 13) and albumin levels with the degree of oral mucositis in allogeneic stem cell transplant patients , 2005, Bone Marrow Transplantation.

[16]  C. Ulrich,et al.  Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  L. Elting,et al.  Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis. , 2004, Seminars in oncology nursing.

[18]  L. Repetto,et al.  Greater risks of chemotherapy toxicity in elderly patients with cancer. , 2003, The journal of supportive oncology.

[19]  Scott B Cantor,et al.  The burdens of cancer therapy , 2003, Cancer.

[20]  D. Cella,et al.  Evaluation of pain associated with oral mucositis during the acute period after administration of high‐dose chemotherapy , 2003, Cancer.

[21]  A. Barasch,et al.  Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. , 2003, Oral oncology.

[22]  L. Rybicki,et al.  A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation , 2002, Bone Marrow Transplantation.

[23]  J. Epstein,et al.  The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. , 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[24]  C. Wenzel,et al.  Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment , 2001, CA: a cancer journal for clinicians.

[25]  N. Senzer,et al.  Benzydamine HCl for prophylaxis of radiation‐induced oral mucositis , 2001, Cancer.

[26]  P. Sjödén,et al.  Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications , 2001, Supportive Care in Cancer.

[27]  F. Spijkervet,et al.  Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  P. Vreken,et al.  Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  A. Zwinderman,et al.  Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases , 2000, Supportive Care in Cancer.

[30]  G. Jayson,et al.  Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue , 2000, British journal of haematology.

[31]  O. Mutchinick,et al.  High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. , 1999, Molecular genetics and metabolism.

[32]  J. Epstein,et al.  Routine dental diagnostic imaging in hematopoietic cell transplantation. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[33]  J. Epstein,et al.  Oral mucositis in myelosuppressive cancer therapy. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[34]  F. Spijkervet,et al.  Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy , 1999, Cancer.

[35]  M. Vincent,et al.  Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. , 1998, Oral oncology.

[36]  S. Sonis,et al.  A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients , 1993, Cancer.

[37]  D G Altman,et al.  Analysis of serial measurements in medical research. , 1990, BMJ.

[38]  L. Matsson,et al.  Oral mucosal lesions in patients with acute leukemia and related disorders during cytotoxic therapy. , 1988, Scandinavian journal of dental research.

[39]  A. P. Barrett,et al.  Clinical characteristics and mechanisms involved in chemotherapy-induced oral ulceration. , 1987, Oral surgery, oral medicine, and oral pathology.

[40]  M. Keating,et al.  Quantitative analysis of the oral complications of antileukemia chemotherapy. , 1986, Oral surgery, oral medicine, and oral pathology.

[41]  V. Farewell,et al.  Using and Understanding Medical Statistics , 1984 .

[42]  J. Lefante,et al.  Treatment of acute myelogenous leukemia: Influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy , 1982, Cancer.

[43]  E. Ramsay,et al.  Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation. , 2007, Clinical therapeutics.

[44]  A. Vissink,et al.  Prevention and treatment of salivary gland hypofunction related to head and neck radiation therapy and chemotherapy. , 2004, Supportive cancer therapy.

[45]  C. Wells,et al.  Comparison of three rating scales for measuring subjective phenomena in clinical research. I. Use of experimentally controlled auditory stimuli. , 2004, Archives of medical research.

[46]  D. Birkhed,et al.  Secretion rate from minor salivary glands in patients with malignant haematological diseases receiving chemotherapy--a pilot study. , 2002, Swedish dental journal.

[47]  A. Molassiotis,et al.  Oral complications in Chinese cancer patients undergoing chemotherapy , 2002, Supportive Care in Cancer.

[48]  J. M. Cohen,et al.  Mexico City : México , 1965 .

[49]  J C GREENE,et al.  THE SIMPLIFIED ORAL HYGIENE INDEX. , 1964, Journal of the American Dental Association.